EQS-CMS: Share Buy-Back Program - 4th Interim Announcement

CompuGroup Medical SE: Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052
CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program – 4th Interim Announcement
In the period from April 15, 2024 until and including April 19, 2024, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 106,540 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on March 26, 2024.
The aggregate number of shares bought back each day during the period from April 15, 2024 until and including April 19, 2024 as well as the daily volume-weighted average prices for such buy-backs are as follows:
 

Date	Aggregate volume (number of no-par value shares)	Volume-weighted average price (in EUR, excluding ancillary costs and charges)
April 15, 2024	21,350	29.9373
April 16, 2024	34,343	29.0553
April 17, 2024	10,000	29.2615
April 18, 2024	20,847	29.1385
April 19, 2024	20,000	29.0579
Total:	106,540	29.2682

The aggregate number of shares bought back within the share buy-back program in the period from March 26, 2024 until and including April 19, 2024 amounts to 380,536 shares.
Detailed information about the transactions are published on the company‘s website under https://www.cgm.com/corp_en/company/ir-en/share.html .
The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading).

Koblenz, April 22, 2024

CompuGroup Medical SE & Co. KGaA
The general partner